Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-EN Version v15-EN
Language English English
Date Updated 2022-03-28 2022-03-18
Drug Identification Number 02281066 02281066
Brand name ABRAXANE FOR INJECTABLE SUSPENSION ABRAXANE FOR INJECTABLE SUSPENSION
Common or Proper name paclitaxel paclitaxel
Company Name CELGENE INC CELGENE INC
Ingredients PACLITAXEL PACLITAXEL
Strength(s) 100MG 100MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size Vial Vial
ATC code L01CD L01CD
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-10-01 2021-10-01
Actual start date
Estimated end date Unknown Unknown
Actual end date 2022-03-18 2022-03-18
Shortage status Resolved Actual shortage
Tier 3 Status No Yes
Company comments Allocation will be based on historical demand. Allocation will be based on historical demand.
Health Canada comments